Access Statistics for Darius Lakdawalla

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Aging and the Growth of Long-Term Care 0 0 2 29 0 1 5 131
Aging and the Growth of Long-Term Care 0 0 0 241 0 1 6 1,282
An Economic Evaluation of the War on Cancer 0 0 1 95 0 1 13 341
Are the Young Becoming More Disabled? 0 0 0 93 0 0 1 340
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer 0 0 0 151 1 1 3 528
Does Medicare Benefit the Poor? New Answers to an Old Question 0 0 0 66 1 1 7 367
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 1 1 22 0 2 11 24
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 84 0 0 9 20
Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey 0 0 0 53 0 1 10 165
Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? 0 0 0 5 1 2 6 25
Effects of expanding health screening on treatment – What should we expect? What can we learn? 0 0 0 5 2 3 10 43
Evaluation of Medical Technologies with Uncertain Benefits 0 0 5 45 0 1 16 30
Food Prices and the Dynamics of Body Weight 0 0 0 66 2 5 14 218
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 3 4 5 624
Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses 0 0 1 13 0 0 5 47
Health Insurance as a Two-Part Pricing Contract 0 0 1 97 0 0 2 418
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 50 0 0 6 180
Insurance and Innovation in Health Care Markets 0 1 2 135 0 1 6 460
Insurance, Self-Protection, and the Economics of Terrorism 0 0 1 287 1 3 11 879
Insurer Bargaining and Negotiated Drug Prices in Medicare Part D 0 0 1 31 1 1 5 137
Insurers' Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 14 0 1 7 94
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 3 0 3 6 67
Intellectual Property and Marketing 1 1 2 89 3 10 16 342
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 34 0 1 8 120
International Differences in Longevity and Health and their Economic Consequences 0 0 0 54 0 1 9 164
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 1 5 13 247
Mortality Risk, Insurance, and the Value of Life 1 2 2 34 1 4 11 26
Nonprofit Production 0 0 0 0 0 0 2 184
Nonprofit Production and Competition 0 0 1 292 0 1 5 1,225
Optimal Liability for Terrorism 0 0 0 40 0 1 8 207
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D 0 0 0 18 0 1 12 66
The Declining Quality of Teachers 0 0 0 220 0 2 6 1,662
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 1 2 9 485 10 19 50 1,529
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 1 87 1 2 12 352
The Insurance Value of Medical Innovation 0 0 1 28 0 1 14 78
The Rise in Old Age Longevity and the Market for Long-Term Care 0 0 0 0 1 3 7 750
The Rise in Old Age Longevity and the Market for Long-Term Care 0 1 3 232 1 4 9 1,759
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 1 28 0 0 12 152
The Welfare Effects of Medical Malpractice Liability 0 0 0 101 1 2 15 445
The Welfare Effects of Public Drug Insurance 0 0 1 76 0 0 6 281
Time-Inconsistency and Welfare 0 0 2 78 0 0 8 365
Understanding Health Disparities Across Education Groups 0 0 1 390 0 3 13 1,660
Understanding the Economic Consequences of Shifting Trends in Population Health 1 1 2 50 1 1 14 174
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 1 36 0 0 6 108
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 1 42 0 0 8 216
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market 0 0 0 15 1 2 17 66
Total Working Papers 4 9 43 4,149 33 95 445 18,598


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies 0 0 5 52 1 1 23 203
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis 1 1 2 2 2 2 6 11
A Theory of Health Disparities and Medical Technology 1 1 8 116 3 5 29 471
An economic evaluation of the war on cancer 0 0 3 101 2 5 26 501
Are Biopharmaceutical Budget Caps Good Public Policy? 0 0 3 12 5 11 26 55
Are investments in disease prevention complements? The case of statins and health behaviors 0 0 0 8 1 2 8 71
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? 0 0 4 34 0 2 29 166
Can the ACA Improve Population Health? 0 0 0 13 0 1 4 58
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer 0 0 1 13 0 0 13 88
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 0 0 0 25 0 0 5 92
Disability Forecasts and Future Medicare Costs 0 0 1 33 2 4 11 258
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets 0 0 0 36 0 0 2 148
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 1 1 0 3 9 9
Does Medicare benefit the poor? 1 3 10 112 1 5 16 281
Economics of the Pharmaceutical Industry 1 12 37 148 7 36 109 363
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 0 0 1 20
Geographic Variation in Health Care: The Role of Private Markets 1 3 8 70 1 10 41 328
HIV Breakthroughs and Risky Sexual Behavior 0 0 2 157 1 5 17 880
HOW DOES HEALTH INSURANCE AFFECT WORKERS’ COMPENSATION FILING? 0 0 0 14 1 2 9 272
HOW DOES TERRORISM RISK VARY ACROSS SPACE AND TIME? AN ANALYSIS BASED ON THE ISRAELI EXPERIENCE 0 0 0 82 1 4 7 269
Healing the poor: The influence of patient socioeconomic status on physician supply responses 0 0 0 3 0 0 9 47
Health insurance as a two-part pricing contract 1 1 2 44 4 7 25 328
Health technology assessment with risk aversion in health 0 0 0 0 1 1 3 3
Innovation and the welfare effects of public drug insurance 0 0 3 40 1 5 12 137
Insurance, self-protection, and the economics of terrorism 0 1 4 65 4 7 24 276
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 1 5 10 1 6 19 101
Is nursing home demand affected by the decline in age difference between spouses? 0 0 0 26 0 2 7 315
Labor Supply and Weight 0 0 4 38 3 3 8 99
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 1 3 42 0 3 13 160
Pharmaceutical advertising and Medicare Part D 0 1 2 10 1 3 18 93
Public Financing and the Market for Long-Term Care 0 0 1 24 1 1 3 97
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets 0 0 1 13 0 1 11 84
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 1 6 34 0 1 27 124
Social insurance and the design of innovation incentives 0 0 1 20 0 0 8 81
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 0 6 66 1 1 24 265
The Economics of Teacher Quality 0 0 0 4 1 1 3 191
The Fiscal Consequences of Trends in Population Health 0 0 0 12 1 1 3 49
The Labor Market Value of Health Improvements 0 0 1 43 1 1 6 148
The Rise in Old-Age Longevity and the Market for Long-Term Care 0 1 3 103 2 10 28 403
The Value of Diagnostic Testing in Personalized Medicine 0 1 2 53 0 4 21 196
The growth of obesity and technological change 0 0 2 27 0 0 5 106
The insurance value of medical innovation 1 1 4 25 2 5 28 107
The nonprofit sector and industry performance 1 4 12 211 3 8 29 607
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions 0 0 0 3 1 2 6 26
The value of medical and pharmaceutical interventions for reducing obesity 0 0 0 12 1 1 10 85
The welfare effects of medical malpractice liability 0 0 0 11 3 8 21 118
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 0 25 0 0 1 95
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 0 55 0 0 3 285
Welfare-Enhancing Technological Change and the Growth of Obesity 0 0 0 148 2 5 15 407
Total Journal Articles 8 33 147 2,199 62 185 781 9,577


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Disability Forecasts and Future Medicare Costs 0 0 0 21 1 1 4 97
Economics of Obesity 0 3 8 31 0 4 14 79
Economics of Obesity 0 1 5 20 1 5 17 71
Food Prices and the Dynamics of Body Weight 0 0 1 13 0 2 5 62
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 0 2 6 75 3 6 30 188
Medical Care Output and Productivity in the Nonprofit Sector 0 0 0 12 0 0 2 59
Public Financing and the Market for Long-Term Care 0 0 0 8 3 4 4 49
Total Chapters 0 6 20 180 8 22 76 605


Statistics updated 2021-01-03